Feds Say Marijuana Has No Known Medical Value, Yet They Hold A Medical Patent

Marijuana is a Schedule 1 Narcotic, meaning that is has no known medical value and is as dangerous as Heroin and Cocaine, which by the way have chemical and synthetic versions used on a daily basis in medicine. So we find it rather ironic that even though the Federal Government states on one side that marijuana and cannabis have no medical value, that they own several patents where they clearly state the medical value and benefits of marijuana and cannabis.

The Federal Government also grows marijuana at the University of Mississippi FOR MEDICAL PURPOSES and supplies this marijuana to FEDERAL MEDICAL MARIJUANA PATIENTS every month.

Don’t you find it strange that even though marijuana has no known medical value in the governments eyes that they still grow it, hold patents for it and provide it to patients for medical purposes……. Hmm  I don’t know about you but this sounds like either our government is either lying to us or to themselves. Why would you hold a patent for a medical purpose that does not exist. Wait patents are so no one can copy your idea right, so that no one but yourself can profit off of your own work without licensing it out to them….. Correct. Well now it starts to sound like a lie for monetary gain in some way.

 

Check out just one of the patents that the feds own below and tell us what you think!

 

Publication number US6630507 B1
Publication type Grant
Application number US 09/674,028
PCT number PCT/US1999/008769
Publication date Oct 7, 2003
Filing date Apr 21, 1999
Priority date Apr 21, 1998
Fee status Paid
Also published as CA2329626A1, 4 More »
Inventors Aidan J. Hampson, Julius Axelrod, Maurizio Grimaldi
Original Assignee The United States Of America As Represented By The Department Of Health And Human Services
Export Citation BiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet

 

Cannabinoids as antioxidants and neuroprotectants
US 6630507 B1
Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.

Justin Meerkat

Cannabis Entrepreneur & Cofounder GetHigh.com | Follow @justinmeerkat on Instagram

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Menu